Mastura M. Yusof

Petaling Jaya, Malaysia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Journal: Frontiers in oncology

Published: February 10, 2026

Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Journal: Frontiers in oncology

Published: October 08, 2024

Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.

Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.

Journal: Frontiers in oncology

Published: October 08, 2024

Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC.

Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC.

Journal: NPJ breast cancer

Published: January 24, 2024

Multidisciplinary Implementation of Neoadjuvant Therapy for Early Breast Cancer in a Middle-income Country-Real-world Challenges in Malaysia.

Multidisciplinary Implementation of Neoadjuvant Therapy for Early Breast Cancer in a Middle-income Country-Real-world Challenges in Malaysia.

Journal: Asia-Pacific journal of clinical oncology

Published: August 29, 2023

Barriers in access to oncology drugs - a global crisis.

Barriers in access to oncology drugs - a global crisis.

Journal: Nature reviews. Clinical oncology

Published: October 05, 2022

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Journal: The New England journal of medicine

Published: July 20, 2022

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.

Journal: Lancet (London, England)

Published: June 26, 2020

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study.

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study.

Journal: BMC cancer

Published: April 02, 2019

The efficacy and tolerability of scalp cooling in preventing chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy in an Asian setting.

The efficacy and tolerability of scalp cooling in preventing chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy in an Asian setting.

Journal: Indian journal of cancer

Published: January 04, 2019

Challenges in supportive cancer care: perspectives from the Asia Pacific and Middle East.

Challenges in supportive cancer care: perspectives from the Asia Pacific and Middle East.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: April 26, 2016

Safety and Management of Toxicity Related to Aflibercept in Combination with Fluorouracil, Leucovorin and Irinotecan in Malaysian Patients with Metastatic Colorectal Cancer.

Safety and Management of Toxicity Related to Aflibercept in Combination with Fluorouracil, Leucovorin and Irinotecan in Malaysian Patients with Metastatic Colorectal Cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: April 05, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026